Spine fusion
Conditions
Interventions
The placebo group (30 patients) will receive two unflavored maltodextrin envelopes, 15 g each (114 Kcal / 0g protein) The experimental group (30 patients) will receive two 15g whey protein envelopes (
Sponsors
Hospital de Acidentados Clínica Santa Isabel
Centro Estadual de Reabilitação e Readaptação Dr. Henrique Santillo (CRER)
Centro Universitário de Brasília- Uniceub
Eligibility
Age
50 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients undergoing lumbar or thoraco- lumbar spine surgery regardless of etiology aged between 50 and 75 years.
Exclusion criteria
Exclusion criteria: Patients with chronic kidney disease with a glomerular filtration rate below 30 ml min; diabetic patients treated with insulin therapy; allergic to milk protein; with malignancy; bedridden previously for diseases not related to spine pathology; with inability to complete quality of life questionnaires; previously submitted to spine surgery; with spinal neurological deficit.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to reduce the loss of handgrip strength after lumbar or thoraco-lumbar spine surgery, with statistical significance, measured 1 to 3 months after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to reduce the loss of appendicular muscle mass index measured 1- 3 months by DEXA, after lumbar or thoraco-lumbar spine surgery, with statistical significance;To evaluate the reduction in the rate of surgical site infection after surgery, with statistical significance | — |
Countries
Brazil
Contacts
Public ContactRodrigo Gonçalves
Centro Estadual de Reabilitação e Readaptação Dr. Henrique Santillo (CRER)
Outcome results
None listed